Table 2 Logistic regression analysis of high-grade and any grade complications

 Age (≧80 vs <80)

1.560

0.465–5.234

0.471

1.648

0.403–6.734

0.487

 Sex (male vs female)

0.332

0.096–1.147

0.081

0.268

0.061–1.182

0.082

 PLND (yes vs no)

0.682

0.142–3.267

0.632

1.193

0.165–8.648

0.861

 ASA score(>2 vs ≤2)

1.875

0.607–5.796

0.275

4.662

1.036–20.968

0.045

 CCI (continuous variable)

0.754

0.372–1.527

0.433

0.463

0.168–1.279

0.138

 EBL, ml (>500ml vs ≤500ml)

0.975

0.294–3.238

0.968

0.672

0.138–3.283

0.623

 Transfusion (yes vs no)

0.838

0.253–2.776

0.773

0.936

0.206–4.250

0.932

 Urinary diversion

0.477

0.354

  Ileal conduit vs ureterostomy

2.043

0.608–6.868

0.248

2.121

0.600–7.501

0.243

  Ileal conduit vs neobladder

2.472

0.249–24.561

0.440

4.881

0.366–65.026

0.230

 Age (≧80 vs <80)

0.849

0.437–1.652

0.630

0.831

0.395–1.748

0.626

 Sex (male vs female)

0.680

0.299–1.545

0.357

1.957

0.804–4.764

0.139

 PLND (yes vs no)

0.851

0.351–2.066

0.722

0.953

0.341–2.664

0.928

 ASA score(>2 vs ≤2)

1.210

0.704–2.080

0.490

0.872

0.438–1.737

0.698

 CCI (continuous variable)

1.413

0.998–2.000

0.052

1.608

1.035–2.497

0.035

 EBL, ml (>500ml vs ≤500ml)

0.752

0.414–1.367

0.349

0.706

0.343–1.456

0.346

 Transfusion (yes vs no)

0.840

0.470–1.503

0.557

0.831

0.407–1.700

0.613

 Urinary diversion

0.813

0.556

  Ileal conduit vs ureterostomy

1.081

0.620–1.884

0.784

1.075

0.600–1.927

0.807

  Ileal conduit vs neobladder

1.533

0.406–5.788

0.529

2.184

0.532–8.975

0.279